The white blood cell and plasma fibrinogen in thrombotic stroke. A significant correlation

International Angiology

Volumn 17, Issue 2, 1998, Pages 120-124

  Belch, J ^a   Mclaren, M ^a   Hanslip, J ^a   Hill, A ^a   Davidson, D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cerebral embolism and thrombosis; Fibrinogen; Free radicals; Leukocytes

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; FREE RADICAL; MALONALDEHYDE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE AGGREGATION; MALE; STROKE; THROMBOSIS;

AGED; CASE-CONTROL STUDIES; CELL ADHESION; CELL AGGREGATION; FEMALE; FIBRINOGEN; FREE RADICALS; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; LEUKOCYTES; MALE; MALONDIALDEHYDE;

EID: 0031785777     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MacWalter RS. Potential developments in stroke rehabilitation and care. Scot Med J 1993;38:12-4.
2. Isles CG. Recent developments in primary prevention of stroke. Scot Med J 1993;38:6-7.
3. Sandercock PAG, Warlow CP, Jones LN, Starkey IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J 1989;298:75-80.
4. Sandercock PAG. Recent development in secondary prevention of stroke. Scot Med J 1993;38:10-1.
5. Pilgeram LO, Chee AN, Bussche GVD. Evidence for abnormality in clotting and thrombolysis as a risk factor for stroke. Stroke 1973;4:643-57.
6. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr. Hemostatic markers in acute stroke. Stroke 1989; 20:592-7.
7. Meade TW. Haemostatic function and arterial disease. Br Med Bull 1994;50:755-75.
8. McCarron RM, Doron DA, Siren AL, Feverstein G, Heldman E, Pollard HB et al. Agonist-stimulated release of von Willebrand factor and pro-coagulant factor VIII in rats with and without risk factors for stroke. Brain Res 1994;647:265-72.
9. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J 1988;296:316-20.
10. Antiplatelet Trialists' Collaboration, Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320-31.
11. Tohgi H, Kawashima M, Tamura K, Suzuki H. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990;21:1663-7.
12. Galante A, Pietroiusti A, Silvestrini M, Stanzione P, Domenici B, Bernardi G. Leukocyte and platelet aggregation in patients with ischaemic stroke: a case controlled study. Eur Neurol 1993;33:442-5.
13. Prentice RL, Szatrowski TP, Kato H, Mason MW. Leukocyte counts and cerebrovascular disease. J Chron Dis 1982;35:703-14.
14. Lowe GDO, Jaap M, Forbes CD. Relation of atrial fibrillation and haematocrit to mortality in acute stroke. Lancet 1983;i:784-6.
15. Belch JJF. The role of the white blood cell in arterial disease. Blood Coag Fibrinolys 1990;1:183-92.
16. Bridges AR, Fisher TC, Scott N, McLaren M, Belch JJF. Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Rad Res Comm 1992;16:89-97.
17. 2, in healthy volunteers. Blood Coag Fibrinolys 1991;2:447-52.
18. Fischer TC, Belch JJF, Barbenel JC, Fisher AC. In vitro human whole blood granulocyte aggregation. Clin Sci 1989;76:183-7.
19. Belch JJF, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991;65:245-8.
20. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke 1990;21:989-92.
21. Mercuri M, Ciuffetti G, Robertson M, Toole J. Blood cell rheology in acute cerebral infarction. Stroke 1989;20:959-62.
22. Ruggeri ZM. von Willebrand factor and fibrinogen. Curr Opin Cell Biol 1993;5:898-906.
23. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993;73:1423-34.
24. Maple C, Kirk G, McLaren M, Belch JJF. A circadian variation exists for plasma levels of intracellular adhesion molecule-1 and E-selectin in healthy volunteers (submitted for publication).
25. Wroe SJ, Sandercock P, Bamford J, Dennis M, Slattery J. Diurnal variation in incidence of stroke: Oxfordshire Community Project. Br Med J 1992;304:155-7.
26. Schmid-Schonbein GW, Engler RL. Granulocytes as active participants in acute myocardial ischemia and infarction. Am J Cardiovasc Pathol 1986;1:15-30.
27. Vermes I, Strik E. Altered leukocyte rheology in patients with chronic cerebrovascular disease. Stroke 1988;19:631-3.
28. Grau AJ, Berger E, Paul Sung K-L, Geert W. Granulocyte adhesion, deformability and superoxide formation in acute stroke. Stroke 1992;23:33-9.
29. Kontos HA. Oxygen radicals in cerebral ischemia. In: Ginsberg MD, Dietrich WD, editors. Cerebrovascular Diseases. 16th Princeton Conference. New York: Raven Press Publishers, 1989:365-71.
30. Hall ED, Braughler JM. Central nervous system trauma and stroke. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Rad Biol Med 1989;6:303-13.
31. Watson BD, Ginsberg MD. Ischaemic injury in the brain. Role of oxygen radical-mediated processes. Ann N Y Acad Sci 1989;559:269-81.